Business Wire

Altman Solon Selects Mindbreeze to Power Knowledge Management and Collaboration Across the Organization

Share

Mindbreeze, a leading global provider of AI-based knowledge management solutions, today announced that Altman Solon, the world’s largest strategy consulting firm focused exclusively on telecommunications, media, and technology (TMT), has purchased Mindbreeze InSpire. The collaboration began in July 2025 with a trial of the Mindbreeze Insight Workplace, designed to unify Altman Solon’s SharePoint and web-based data sources into a single point of entry for organizational knowledge.

Before partnering with Mindbreeze, Altman Solon sought to enhance how its global teams accessed and shared knowledge across systems, a challenge common among consulting firms with vast, fast-growing data ecosystems. The company had built a strong foundation in SharePoint for managing structured project data, but its native search capabilities limited visibility across platforms. Project information was distributed across several secure repositories, making it difficult to form a single, holistic view of our collective knowledge. Without a centralized intelligence interface, teams spent valuable time consolidating data manually, slowing collaboration and onboarding. In a knowledge-driven business, even simple questions such as “Who leads this project?” or “What is the fiber penetration rate in Mexico?” require instant, trusted answers, something Altman Solon wanted to provide across all departments within the firm.

Within just a few weeks:

  • July 7 – Start of data indexing and Insight Workplace setup.
  • August 11 – User acceptance testing started ahead of schedule due to strong positive feedback.
  • September 8 – Altman Solon finalized its purchase of Mindbreeze for a three-year term, with a full company-wide rollout planned immediately.
  • September 12 – Go-live.

With Mindbreeze, Altman Solon rapidly transformed the way its consultants interact with firm knowledge. Instead of navigating multiple systems that provided inconsistent search results, consultants now access a unified, AI-powered platform that connects insights, projects, and documents firmwide. Project data that was once stored across siloed environments is now indexed and intelligently linked, making it easy to surface context-rich insights and historical benchmarks in seconds. Where manual searching once consumed time, AI-driven Q&A capabilities now deliver accurate, source-cited responses instantly — empowering teams to move faster and with greater confidence. The integration of Mindbreeze has streamlined project ramp-up, improved collaboration, and enhanced client delivery — a tangible step forward in Altman Solon’s broader digital transformation.

“Mindbreeze quickly proved valuable, helping us move from pilot to full implementation within weeks,” said Alex Dumke, COO at Altman Solon. “Our teams now have easier access to project insights and IP, which supports better collaboration and more informed decision-making across our global teams.”

“Working with Mindbreeze has been refreshingly agile and transparent,” said Kimberly Padilla, Global Head of Knowledge Management at Altman Solon. “In just weeks, we progressed from data indexing to full user acceptance testing. Today, consultants can access and interact with firm knowledge in ways that make collaboration faster, smarter, and more intuitive.”

The Mindbreeze Insight Workplace equips Altman Solon with:

  • Real-time natural language search across structured and unstructured data.
  • Comprehensive 360-degree project views, including leadership, documentation, and client details.
  • AI-driven recommendations that make knowledge more accessible and actionable.
  • A collaborative hub that breaks down silos and accelerates decision-making.
  • Seamless integration of the Insight Workplace in MS Teams.

“Altman Solon’s swift decision to purchase Mindbreeze underscores both the urgency of modern knowledge management and the power of our solution to meet those needs,” said Daniel Fallmann, CEO and Founder of Mindbreeze. “From day one, their teams embraced the Insight Workplace, and within weeks it became clear that this was the right fit for their organization.”

About Altman Solon

Altman Solon is the world’s largest strategy consulting firm dedicated exclusively to the telecommunications, media, and technology (TMT) sectors. With offices across the Americas, Europe, and Asia, Altman Solon partners with global leaders to address their most critical strategic challenges.

About Mindbreeze

Mindbreeze is a global leader in AI-powered enterprise intelligence, with headquarters in Europe and the United States. Mindbreeze InSpire redefines how organizations access and utilize information. Powered by advanced AI, it transforms complex data into actionable insights, seamlessly connecting and analyzing information across systems.

Unlike traditional solutions, our AI agents deliver hyper-relevant, context-aware insights tailored to unique business needs, enabling smarter, faster decision-making. With unmatched integration capabilities, data security, and automation at its core, Mindbreeze InSpire maximizes the value of your information ecosystem while driving innovation.

Trusted by industry leaders and recognized for our cutting-edge technology, Mindbreeze leads the way in unlocking new dimensions of enterprise intelligence.

Learn more at www.mindbreeze.com or follow us on LinkedIn and X @Mindbreeze.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251110464028/en/

Contacts

Press contact
Mindbreeze
Britney Chandler
+1-312-300-6745
pr@mindbreeze.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press Release

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press Release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr

Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press Release

The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p

Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press Release

Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive Officer, Lattice Semiconductor. The annual GSA Awards celebrate the accomplishments of the semiconductor indu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye